Glucuronidation (WP698)
Homo sapiens
Metabolism of xenobiotic compounds consists of phase I and a phase II biotransformation reactions, being compound modification and conjugation reactions respectively. In phase I biotransformation, the compound is modificated via oxidation, reduction, hydrolysis, or other minor reactions, to reveal a reactive group to which a conjugation molecule can react to. In phase II, a small conjugation molecule reacts with the phase I modified molecule, producing a much more water-soluble molecule that can be excreted more easily. Glucuronidation is a phase II biotransformation reaction in which glucuronide acts as a conjugation molecule and binds to a substrate via the catalysis of glucuronosyltransferases. First, in a series of reactions the cosubstrate uridine diphosphate glucuronic acid (UDPGA) is formed. The glucuronosyltransferases (UGTs) then catalyze the transfer of glucuronic acid from UDPGA to a substrate resulting in a glucuronidated substrate and leaving uridine 5'-diphosphate. UGTs are a very broad and divers group of enzymes and count as the most significant group of conjugation enzymes in xenobiotic metabolism, qualitatively because glucuronic acid can be coupled to a large diversity of functional groups and quantitatively because of the large and divers number of substrates that are formed. Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP698 CPTAC Assay Portal]
Authors
Pieter Giesbertz , Alex Pico , Egon Willighagen , Denise Slenter , Kristina Hanspers , and Eric WeitzActivity
Discuss this pathway
Check for ongoing discussions or start your own.
Cited In
Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.
Organisms
Homo sapiensCommunities
Annotations
Pathway Ontology
glucuronidation conjugation pathwayLabel | Type | Compact URI | Comment |
---|---|---|---|
Adenosine 3',5'-diphosphate | Metabolite | hmdb:HMDB0000061 | |
2H+ | Metabolite | chebi:15378 | |
Glucose 6-phosphate | Metabolite | hmdb:HMDB0001401 | |
Uridine 5'-diphosphate | Metabolite | hmdb:HMDB0000295 | |
NAD | Metabolite | hmdb:HMDB0000902 | |
Water | Metabolite | hmdb:HMDB0002111 | |
Adenosine triphosphate | Metabolite | hmdb:HMDB0000538 | |
NADH | Metabolite | hmdb:HMDB0001487 | |
Uridine diphosphate glucose | Metabolite | hmdb:HMDB0000286 | |
Phosphate | Metabolite | hmdb:HMDB0001429 | |
Glucose 1-phosphate | Metabolite | hmdb:HMDB0001586 | |
Uridine diphosphate glucuronic acid | Metabolite | hmdb:HMDB0000935 | |
Uridine triphosphate | Metabolite | hmdb:HMDB0000285 | |
D-Glucose | Metabolite | hmdb:HMDB0000122 | |
UGP2 | GeneProduct | ensembl:ENSG00000169764 | |
PGM3 | GeneProduct | ensembl:ENSG00000013375 | |
PGM5 | GeneProduct | ensembl:ENSG00000154330 | |
PGM2 | GeneProduct | ensembl:ENSG00000169299 | |
HK1 | GeneProduct | ensembl:ENSG00000156515 | |
UGDH | GeneProduct | ensembl:ENSG00000109814 | |
PGM1 | GeneProduct | ensembl:ENSG00000079739 | |
UGT2B17 | GeneProduct | ncbigene:7367 | |
UGT1A4 | GeneProduct | ncbigene:54657 | |
UGT1A8 | GeneProduct | ncbigene:54576 | |
UGT2A3 | GeneProduct | ncbigene:79799 | |
UGT1A6 | GeneProduct | ncbigene:54578 | |
UGT2B15 | GeneProduct | ncbigene:7366 | |
UGT2B4 | GeneProduct | ncbigene:7363 | |
UGT2B10 | GeneProduct | ncbigene:7365 | |
UGT1A10 | GeneProduct | ncbigene:54575 | |
UGT1A5 | GeneProduct | ncbigene:54579 | |
UGT2A1 | GeneProduct | ncbigene:10941 | |
UGT1A1 | GeneProduct | ncbigene:54658 | |
UGT1A9 | GeneProduct | ncbigene:54600 | |
UGT2B28 | GeneProduct | ncbigene:54490 | |
UGT2A2 | GeneProduct | ncbigene:574537 | |
UGT2B7 | GeneProduct | ncbigene:7364 | |
UGT2B11 | GeneProduct | ensembl:ENSG00000213759 | |
UGT1A3 | GeneProduct | ncbigene:54659 | |
UGT1A7 | GeneProduct | ncbigene:54577 |
References
- The biochemistry of drug metabolism--an introduction: part 4. reactions of conjugation and their enzymes. Testa B, Krämer SD. Chem Biodivers. 2008 Nov;5(11):2171–336. PubMed Europe PMC Scholia
- Androgen-stimulated UDP-glucose dehydrogenase expression limits prostate androgen availability without impacting hyaluronan levels. Wei Q, Galbenus R, Raza A, Cerny RL, Simpson MA. Cancer Res. 2009 Mar 15;69(6):2332–9. PubMed Europe PMC Scholia